CYRX compared with SIBN: revenue, margins and what each company keeps, and the suppliers and customers both name

CYRXCryoport, Inc.

Mkt capRevenueRevenue

SIBNSi-Bone, Inc.

Mkt capRevenueRevenue

Compare

CYRXCryoport, Inc.

SIBNSi-Bone, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

CYRX: latest quarter is a loss; flow not drawable. SIBN: latest quarter is a loss; flow not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only CYRX 1

—Moffitt Cancer Centerunlistedcustomer

Shared 0

No shared counterparties.

Only SIBN 1

—Dekraunlistedsupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

Price

rebased to 0%

CYRX, solidSIBN, dashed

CYRXCryoport, Inc.

16.22▼−6.19%· post 16.22· delayed

Mkt cap$875.7MRevenue$49MQ2 FY26Revenue$176MFY25

SIBNSi-Bone, Inc.

20.27▼−4.51%· post 20.22· delayed

After hoursNov 2 '26delayed

Mkt cap$951.5MRevenue$56MQ2 FY26Revenue$201MFY25

Compare

After hoursNov 2 '26delayed

CYRXCryoport, Inc.

SIBNSi-Bone, Inc.

16.22▼−6.19%post 16.22delayed

Price

20.27▼−4.51%post 20.22delayed

$875.7M

Mkt cap

$951.5M

Q2 FY26$49M

Revenue

$56MQ2 FY26

FY25$176M

Revenue

$201MFY25

CYRX16.22▼−6.19%vsSIBN20.27▼−4.51%After hoursNov 2 '26delayed